Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Daylight PDT vs Cryosurgery for Facial Actinic Keratoses
NCT02736760Phase 4Completed
- Sponsor
- Universitätsklinikum Regensburg
- Start
- Mar 2016
- Primary completion
- Sep 2018
- Modality
- Light/Condition-Responsive Prodrugs
- Countries
- 1
01
Overview
A Phase 4 trial of methyl aminolevulinate in actinic keratosis (AK), sponsored by Universitätsklinikum Regensburg. Started Mar 2016; status: completed.
02
Drugs
methyl aminolevulinate
03
Conditions
actinic keratosis (AK)
Beyond the preview
Go deeper on NCT02736760.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02736760.